BRG399, a small molecule modulator of UBE2K demonstrated dose-dependent anti-cancer efficacy in an in vivo model for gastric cancerShiva Kazerounian, Mollie O'Hara,Arcan Guven, Kashni Grover, Nicole Pellegrino,Kayleigh Gray,Can Bruce,Gregory M. Miller,Maria-Dorothea Nastke,Michael A. Kiebish,Eric M. Grund,Rangaprasad Sarangarajan,Niven R. Narain,Stephane Gesta,Vivek K. VishnudasCANCER RESEARCH(2022)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要